Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

MLA

Papageorgiou, S. G.Kotsianidis, I.Bouchla, A.Symeonidis, A.Galanopoulos, A.Viniou, N. A.Hatzimichael, E.Vassilakopoulos, T. P.Gogos, D.Megalakaki, A.Zikos, P.Diamantopoulos, P.Kourakli, A.Giannoulia, P.Papoutselis, M.Poulakidas, E.Arapaki, M.Vardi, A.Anagnostopoulos, A.Mparmparousi, D.Papaioannou, M.Bouronikou, E.Dimou, M.Papadaki, H.Panayiotidis, P.Pappa, V. Serum Ferritin and ECOG Performance Status Predict the Response and Improve the Prognostic Value of IPSS or IPSS-R in Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Treated with 5-Azacytidine: A Retrospective Analysis of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..2f1346cbba3a388fdd0c272409f84d91&authtype=sso&custid=ns315887.

APA

Papageorgiou, S. G. K. I. B. A. S. A. G. A. V. N.-A. H. E. V. T. P. G. D. M. A. Z. P. D. P. K. A. G. P. P. M. P. E. A. M. V. A. A. A. M. D. P. M. B. E. D. M. P. H. P. P. P. V. (2020). Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes.

Chicago

Papageorgiou, S.G. Kotsianidis, I. Bouchla, A. Symeonidis, A. Galanopoulos, A. Viniou, N.-A. Hatzimichael, E. Vassilakopoulos, T.P. Gogos, D. Megalakaki, A. Zikos, P. Diamantopoulos, P. Kourakli, A. Giannoulia, P. Papoutselis, M. Poulakidas, E. Arapaki, M. Vardi, A. Anagnostopoulos, A. Mparmparousi, D. Papaioannou, M. Bouronikou, E. Dimou, M. Papadaki, H. Panayiotidis, P. Pappa, V. 2020. “Serum Ferritin and ECOG Performance Status Predict the Response and Improve the Prognostic Value of IPSS or IPSS-R in Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Treated with 5-Azacytidine: A Retrospective Analysis of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..2f1346cbba3a388fdd0c272409f84d91&authtype=sso&custid=ns315887.